Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-05-2024 | Melanoma | Case report

Multiple drugs

Chronic inflammatory demyelinating polyneuropathy and lack of efficacy

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Haider S, et al. Novel treatments for novel side effects: A case report and review of baricitinib use in the treatment of chronic inflammatory demyelinating polyneuropathy caused by immune checkpoint inhibitor use. Journal for ImmunoTherapy of Cancer 11: No. 1, Jan 2023. Available from: URL: https://dx.doi.org/10.1136/jitc-2023-007885 Haider S, et al. Novel treatments for novel side effects: A case report and review of baricitinib use in the treatment of chronic inflammatory demyelinating polyneuropathy caused by immune checkpoint inhibitor use. Journal for ImmunoTherapy of Cancer 11: No. 1, Jan 2023. Available from: URL: https://​dx.​doi.​org/​10.​1136/​jitc-2023-007885
Metadata
Title
Multiple drugs
Chronic inflammatory demyelinating polyneuropathy and lack of efficacy
Publication date
01-05-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-58787-6

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Multiple drugs

Case report

Metamfetamine

Case report

Multiple drugs

Case report

Mobocertinib